68 related articles for article (PubMed ID: 21615719)
1. Secondary cancers following allogeneic haematopoietic cell transplantation in adults.
Majhail NS
Br J Haematol; 2011 Aug; 154(3):301-10. PubMed ID: 21615719
[TBL] [Abstract][Full Text] [Related]
2. Secondary solid cancer screening following hematopoietic cell transplantation.
Inamoto Y; Shah NN; Savani BN; Shaw BE; Abraham AA; Ahmed IA; Akpek G; Atsuta Y; Baker KS; Basak GW; Bitan M; DeFilipp Z; Gregory TK; Greinix HT; Hamadani M; Hamilton BK; Hayashi RJ; Jacobsohn DA; Kamble RT; Kasow KA; Khera N; Lazarus HM; Malone AK; Lupo-Stanghellini MT; Margossian SP; Muffly LS; Norkin M; Ramanathan M; Salooja N; Schoemans H; Wingard JR; Wirk B; Wood WA; Yong A; Duncan CN; Flowers ME; Majhail NS
Bone Marrow Transplant; 2015 Aug; 50(8):1013-23. PubMed ID: 25822223
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type" [Transplantation Reviews 2024; 38(2):100837].
Ergisi M; Ooi B; Salim O; Papalois V
Transplant Rev (Orlando); 2024 Apr; 38(2):100843. PubMed ID: 38538506
[No Abstract] [Full Text] [Related]
4. Cancer Prevalence in Children with Inborn Errors of Immunity: Report from a Single Institution.
Mitchell MR; Urdinez L; Bernasconi AR; Danielian S; Katsikas MM; Sajaroff EO; Roffé G; Villa NM; Galluzzo L; Sanz M; Palma AM; Bouso C; Prieto E; Goris V; Yancoski J; Rosenzweig SD; Oleastro M; Rosé A; Cacciavillano W; Felizzia G; Guitter M; Sánchez La Rosa C; Ríos M; Zubizarreta P; Felice MS; Rossi JG
J Clin Immunol; 2024 May; 44(6):138. PubMed ID: 38805138
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe.
Rafii H; Ruggeri A; Kenzey C; Sanz J; Peffault De La Tour R; Esquirol A; Michel G; Chevallier P; Rubio MT; Cornelissen JJ; Michallet M; Volt F; Rivera-Franco MM; Scigliuolo GM; Cappelli B; Rocha V; Gluckman E
Blood Adv; 2023 May; 7(10):1976-1986. PubMed ID: 36350759
[TBL] [Abstract][Full Text] [Related]
6. Donor-derived lymphoma harboring a mosaic sex chromosome in a female stem cell transplantation recipient from a male sibling.
Imataki O; Kubo H; Kida JI; Uemura M; Fujita H; Kadowaki N
EJHaem; 2022 Feb; 3(1):228-230. PubMed ID: 35846214
[No Abstract] [Full Text] [Related]
7. Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.
Lee CJ; Kim S; Tecca HR; Bo-Subait S; Phelan R; Brazauskas R; Buchbinder D; Hamilton BK; Battiwalla M; Majhail NS; Lazarus HM; Shaw PJ; Marks DI; Litzow MR; Chhabra S; Inamoto Y; DeFilipp Z; Hildebrandt GC; Olsson RF; Kasow KA; Liesveld JL; Rotz SJ; Badawy SM; Bhatt NS; Yared JA; Page KM; Arellano ML; Kent M; Farhadfar N; Seo S; Hematti P; Freytes CO; Rovó A; Ganguly S; Nathan S; Burns L; Shaw BE; Muffly LS
Blood Adv; 2020 Mar; 4(6):983-992. PubMed ID: 32168378
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.
Majhail NS; Murphy E; Laud P; Preussler JM; Denzen EM; Abetti B; Adams A; Besser R; Burns LJ; Cerny J; Drexler R; Hahn T; Idossa L; Jahagirdar B; Kamani N; Loren A; Mattila D; McGuirk J; Moore H; Reynolds J; Saber W; Salazar L; Schatz B; Stiff P; Wingard JR; Syrjala KL; Baker KS
Haematologica; 2019 May; 104(5):1084-1092. PubMed ID: 30514795
[TBL] [Abstract][Full Text] [Related]
9. Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.
Denzen EM; Preussler JM; Murphy EA; Baker KS; Burns LJ; Foster J; Idossa L; Moore HK; Payton TJ; Haven D; Jahagirdar B; Kamani N; Rizzo JD; Salazar L; Schatz BA; Syrjala KL; Wingard JR; Majhail NS
Biol Blood Marrow Transplant; 2019 Mar; 25(3):562-569. PubMed ID: 30315940
[TBL] [Abstract][Full Text] [Related]
10. Sezary syndrome manifesting as posttransplant lymphoproliferative disorder.
Afiat TP; Zhang X; Zhang H; Ayala E; Zhang L; Sokol L
Leuk Res Rep; 2018; 9():72-75. PubMed ID: 29761072
[TBL] [Abstract][Full Text] [Related]
11. Second Malignancies after Hematopoietic Stem Cell Transplantation.
Danylesko I; Shimoni A
Curr Treat Options Oncol; 2018 Feb; 19(2):9. PubMed ID: 29423555
[TBL] [Abstract][Full Text] [Related]
12. Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
Brás G; Pinho-Vaz C; Campos A
Case Rep Med; 2017; 2017():9674385. PubMed ID: 28839454
[TBL] [Abstract][Full Text] [Related]
13. Long-term complications after hematopoietic cell transplantation.
Majhail NS
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):220-227. PubMed ID: 28641097
[TBL] [Abstract][Full Text] [Related]
14. Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry.
Mayor PC; Eng KH; Singel KL; Abrams SI; Odunsi K; Moysich KB; Fuleihan R; Garabedian E; Lugar P; Ochs HD; Bonilla FA; Buckley RH; Sullivan KE; Ballas ZK; Cunningham-Rundles C; Segal BH
J Allergy Clin Immunol; 2018 Mar; 141(3):1028-1035. PubMed ID: 28606585
[TBL] [Abstract][Full Text] [Related]
15. Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes.
Hamblin A; Greenfield DM; Gilleece M; Salooja N; Kenyon M; Morris E; Glover N; Miller P; Braund H; Peniket A; Shaw BE; Snowden JA
Bone Marrow Transplant; 2017 Jun; 52(6):889-894. PubMed ID: 28436977
[TBL] [Abstract][Full Text] [Related]
16. Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor.
Kinsella FA; Amel Kashipaz MR; Scarisbrick J; Malladi R
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28073814
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.
Battiwalla M; Tichelli A; Majhail NS
Biol Blood Marrow Transplant; 2017 Feb; 23(2):184-192. PubMed ID: 27818318
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma Multiforme in a Post Allogeneic Stem Cell Transplant Patient. A Case Report and Literature Review of Post Transplant Neurological Tumors.
Ganapule AP; Varghese SS; Chacko G; Aparna I; Viswabandya A
Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):192-5. PubMed ID: 27408389
[TBL] [Abstract][Full Text] [Related]
19. Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology.
Rioth MJ; Warner J; Savani BN; Jagasia M
Bone Marrow Transplant; 2016 Jan; 51(1):34-40. PubMed ID: 26367235
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up after allogeneic stem cell transplantation.
Hilgendorf I; Greinix H; Halter JP; Lawitschka A; Bertz H; Wolff D
Dtsch Arztebl Int; 2015 Jan; 112(4):51-8. PubMed ID: 25797423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
